Sound Income Strategies LLC lifted its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 7.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,089 shares of the pharmacy operator’s stock after purchasing an additional 138 shares during the quarter. Sound Income Strategies LLC’s holdings in CVS Health were worth $194,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in the company. Macroview Investment Management LLC raised its position in shares of CVS Health by 128.3% in the first quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 136 shares during the period. Claremont Financial Group Inc. acquired a new position in shares of CVS Health during the 4th quarter valued at about $26,000. Stuart Chaussee & Associates Inc. grew its holdings in shares of CVS Health by 123.0% in the first quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 171 shares during the period. Rise Advisors LLC purchased a new position in CVS Health during the fourth quarter worth about $41,000. Finally, Carl Stuart Investment Advisor Inc. purchased a new position in CVS Health in the first quarter worth approximately $41,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on CVS. Tigress Financial raised their price target on CVS Health from $125.00 to $130.00 in a research report on Wednesday, August 17th. Loop Capital began coverage on CVS Health in a research report on Thursday, June 16th. They set a “buy” rating and a $120.00 price objective on the stock. UBS Group boosted their target price on CVS Health from $118.00 to $127.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Sanford C. Bernstein downgraded CVS Health from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $122.00 to $112.00 in a research report on Thursday, May 26th. Finally, Credit Suisse Group raised their target price on shares of CVS Health from $113.00 to $117.00 and gave the company an “outperform” rating in a report on Monday, August 8th. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $117.59.
CVS Health Stock Down 0.2 %
CVS Health (NYSE:CVS – Get Rating) last announced its quarterly earnings data on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.16 by $0.24. The company had revenue of $80.64 billion for the quarter, compared to analysts’ expectations of $76.38 billion. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. CVS Health’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.42 EPS. As a group, research analysts expect that CVS Health Co. will post 8.53 earnings per share for the current year.
CVS Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Friday, July 22nd were issued a $0.55 dividend. The ex-dividend date was Thursday, July 21st. This represents a $2.20 annualized dividend and a dividend yield of 2.16%. CVS Health’s dividend payout ratio is currently 35.77%.
Insider Buying and Selling
In other CVS Health news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the sale, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the sale, the executive vice president now owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 138,654 shares of CVS Health stock in a transaction on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the transaction, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at $59,495,935. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by corporate insiders.
CVS Health Company Profile
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.